aXichem AB (AXIC-A.ST)
aXichem AB operates in the Chemicals - Specialty industry of the Basic Materials sector, headquartered in Malmö, SN, SE. The stock last traded at $2.10, down 2.33% on the session, giving a market capitalisation of $142.2M. Its beta of -0.69 implies it has historically moved less than the broad market.
aXichem AB is a biotechnology firm, established in 2007 and headquartered in Malmö, Sweden, that specializes in creating natural analogue compounds. The company offers aXivite, a capsaicin analogue solution designed for various dietary health applications. Another key product, aXiphen-bio, functions as a biological repellent, providing antifouling protection for marine vessels and installations, and managing pests in agriculture, forestry, and for safeguarding cable infrastructure both within buildings and underground. Additionally, aXiphen-feed is developed to boost the health of poultry, including chickens and hens, as well as swine, such as pigs and piglets.
aXichem AB is most often compared with the following Basic Materials names: